TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Clinical trial NCT00023413 · COMPLETED

Trial details

NCT number: NCT00023413
Sponsor: Centers for Disease Control and Prevention
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Infections Tuberculosis

Start date: 1999-11-01
Primary completion: 2004-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.